This protocol is judged by an institutional evaluate board, an unbiased team that evaluations any medical trials involving people. If a study requires a Timetable I drug, when the board approves the protocol as ethical, the scientists need to make an application for an investigational new drug (IND) amount with the FDA.While using the doses package